MIRA
INFORM REPORT
|
Report Date : |
07.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
DOHA PHARMACEUTICAL COMPANY LIMITED |
|
|
|
|
Registered Office : |
No. 30 Tran Phu Collective Zone, Alley 105 Nguyen Phong Sac Str, Group
16, Dich Vong Ward, Cau Giay Dist, Hanoi City. |
|
|
|
|
Country : |
Vietnam |
|
|
|
|
Date of Incorporation : |
2006 |
|
|
|
|
Com. Reg. No.: |
0102025516 |
|
|
|
|
Legal Form : |
Liability Company Limited |
|
|
|
|
Line of Business : |
Trading in Pharmaceutical Products, Chemicals, and Cosmetics |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
New and Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
SUBJECT IDENTIFICATION &
LEGAL FORM
|
|
||
English Name
|
|
DOHA PHARMACEUTICAL COMPANY LIMITED
|
|
Vietnamese name |
|
CONG TY TNHH
DUOC PHAM DO HA |
|
Trade name |
|
DOHA PHARMA CO.,
LTD |
|
Legal Status |
|
Liability Company Limited |
|
Founded |
|
2006 |
|
Business Registration No. |
|
0102025516 |
|
Date of Issuance |
|
March 27th, 2006 |
|
Place of Issuance |
|
Hanoi Planning and Investment Department |
|
Registered Capital |
|
500,000,000 VND |
|
Tax Code |
|
0101902050 |
|
Total Employees |
|
About 60 (Staffs and Freelances) |
|
Qualification |
|
Normal |
|
|
||
ADDRESSES
|
|
||
Head Office
|
||
|
Address |
|
No. 30 Tran Phu Collective Zone, Alley 105
Nguyen Phong Sac Str, Group 16, Dich Vong Ward, Cau Giay Dist, Hanoi City. |
|
Country |
|
Vietnam |
|
Tel |
|
(84-4) 7566123 |
|
|
||
DIRECTORS
|
|
||
|
1.
NAME |
|
Mr.
TRAN DUY DONG |
|
Position |
|
Director |
|
ID No. |
|
012811616 |
|
Nationality |
|
Vietnamese |
|
|
||
|
2.
NAME |
|
Mrs.
LUU THI HA |
|
Position |
|
Deputy Director |
|
Nationality |
|
Vietnamese |
|
|
||
BUSNESS ACTIVITIES
|
|
Following are the main business activities of the subject:
|
|
·
Trading in pharmaceutical products, chemicals, and cosmetics ·
Trading medical materials and equipment |
|
|
IMPORT & EXPORT ACTIVITIES
|
|
|
IMPORT: The subject
doesn’t directly imports from foreign countries. Most of products are
imported through delegate company. |
|
EXPORT: N/A |
|
|
BANKERS
|
|
||
|
1.
ASIA COMMERCIAL BANK |
||
|
Acc No |
|
28535639 |
|
Note: The subject doesn’t directly import
good. According to director of the subject, it does not transact with foreign
partner at this bank. All its transactions are done through bank of delegate
company. |
||
|
|
||
SHAREHOLDERS
|
|
||
|
1.
NAME |
|
Mr.
TRAN DUY DONG |
|
Position |
|
Director |
|
ID No. |
|
012811616 |
|
Nationality |
|
Vietnamese |
|
Share |
|
80% |
|
|
||
|
2.
NAME |
|
Mrs.
LUU THI HA |
|
Position |
|
Deputy Director |
|
Nationality |
|
Vietnamese |
|
Share |
|
20% |
|
|
||
PAYMENT HISTORY AND EXPERIENCES
|
|
||
|
Trade Morality |
|
Normal |
|
Liquidity |
|
Normal |
|
Current Payment |
|
Normal |
|
Financial situation |
|
Under Average |
|
Litigation Data |
|
No record |
|
Bankruptcy |
|
No record |
|
Mode of Payment |
|
L/C (According to Mr. Tran Duy Dong, the
subject uses usually L/C mode of payment) |
|
|
||
FINANCIAL DATA
|
The subject was founded in 2006, thus the
financial statement is not available. According to Mr. Tran Duy Dong, its
annual revenue is about 30 billion VND. |
|
|
INTERPRETATION ON THE SCORES
|
The DOHA Pharmaceutical Company Limited (DOHA Pharma co., ltd) was
newly established in 2006 with registration capital of 500 million VND by two
contributors: Mr. Tran Duy Dong (Director) and Mrs. Luu Thi Ha (Deputy
Director). Head office of the subject is located at No. 30 Tran Phu Collective
Zone, Alley 105 Nguyen Phong Sac Str, Group 16, Dich Vong Ward, Cau Giay
Dist, Hanoi City, which is a private house in alley. When we visited, there
is nobody working at this office. We only contacted with Mr. Dong through his
hand phone. According to him, the subject has about 60 sale freelances in
Hochiminh and Hanoi cities and neighboring provinces. Its annual revenue is
about 30 billion VND. The subject has just been established, but Mr. Tran Duy Dong had
worked a long time in this area. However, business activities and financial
status of the subject are not stable. Its market share and position in the
industry is low. The subject only imports goods through Central
Pharmaceutical Company No.2. In general, the subject is
operating on the small scale. It has capacity to meet small business
transactions. |
|
To be graded at B, the
company’s stability is expected to be IMPAIRED by adverse changes in
circumstances and economic conditions. |
|
|
|
CREDIT INQUIRY: 500,000 USD (Against D/A Term) |
|
Not reliable. (max business
transaction of the subject is only about 20,000 USD) |
|
|
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)